Literature DB >> 9129144

A novel germ line p53 mutation in intron 6 in diverse childhood malignancies.

S Avigad1, D Barel, O Blau, A Malka, M Zoldan, C Mor, M Fogel, I J Cohen, B Stark, Y Goshen, J Stein, R Zaizov.   

Abstract

Screening for p53 mutations in exons 5 to 8 in 124 pediatric malignancies identified 18 abnormal shifts using single strand conformation polymorphism: 12 were missense mutations and in 6, no mutation was detected in the exon or in the splice donor acceptor sequences. Sequencing was then performed in the adjacent introns, revealing a G to A base substitution at 39 base pairs upstream to exon 7. This mutation was identified in the germ line of five of the patients, and also in the father of one, whose parents were available. For comparison, of the 184 normal controls similarly screened, only one had this mutation (P=0.036). Positive staining of p53 protein was observed in three of the paraffin embedded tissues that were available: brain tumor, rhabdomyosarcoma, and lymphocytes from a normal lymph node from the rhabdomyosarcoma patient. All tumors with the identified intron mutation were Li-Fraumeni syndrome tumors. Sequencing of all exons including splice sites was performed and revealed no mutation. We suggest that this mutation in intron 6 of the p53 gene stabilizes the wild type p53 protein, resulting in its abnormal accumulation. Mutations in the noncoding region of p53 should be further studied.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129144     DOI: 10.1038/sj.onc.1200990

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Absence of germline and somatic p53 alterations in children with sporadic brain tumors.

Authors:  C Portwine; S Chilton-MacNeill; C Brown; E Sexsmith; J McLaughlin; D Malkin
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

2.  Association of specific genotype and haplotype of p53 gene with cervical cancer in India.

Authors:  S Mitra; C Misra; R K Singh; C K Panda; S Roychoudhury
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

3.  TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.

Authors:  D Mavridou; R Gornall; I G Campbell; D M Eccles
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

4.  Duplex Detection of TP53 Arg72Pro and 16 bp Del/Ins Polymorphisms by a Simple Optimized PCR-RFLP Method.

Authors:  B Lajin; A Alachkar; Sakur A Alhaj
Journal:  N Am J Med Sci       Date:  2012-05

5.  Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.

Authors:  S Wang-Gohrke; W Weikel; H Risch; D Vesprini; J Abrahamson; C Lerman; A Godwin; R Moslehi; O Olipade; J S Brunet; E Stickeler; D G Kieback; R Kreienberg; B Weber; S A Narod; I B Runnebaum
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

6.  Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families.

Authors:  Xuan Liu; Hans-Peter Sinn; Hans Ulrich Ulmer; Rodney J Scott; Ute Hamann
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

7.  Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes.

Authors:  Tyler Landrith; Bing Li; Ashley A Cass; Blair R Conner; Holly LaDuca; Danielle B McKenna; Kara N Maxwell; Susan Domchek; Nichole A Morman; Christopher Heinlen; Deborah Wham; Cathryn Koptiuch; Jennie Vagher; Ragene Rivera; Ann Bunnell; Gayle Patel; Jennifer L Geurts; Morgan M Depas; Shraddha Gaonkar; Sara Pirzadeh-Miller; Rebekah Krukenberg; Meredith Seidel; Robert Pilarski; Meagan Farmer; Khateriaa Pyrtel; Kara Milliron; John Lee; Elizabeth Hoodfar; Deepika Nathan; Amanda C Ganzak; Sitao Wu; Huy Vuong; Dong Xu; Aarani Arulmoli; Melissa Parra; Lily Hoang; Bhuvan Molparia; Michele Fennessy; Susanne Fox; Sinead Charpentier; Julia Burdette; Tina Pesaran; Jessica Profato; Brandon Smith; Ginger Haynes; Emily Dalton; Joy Rae-Radecki Crandall; Ruth Baxter; Hsiao-Mei Lu; Brigette Tippin-Davis; Aaron Elliott; Elizabeth Chao; Rachid Karam
Journal:  NPJ Precis Oncol       Date:  2020-02-24

8.  Intronic SNPs of TP53 gene in chronic myeloid leukemia: Impact on drug response.

Authors:  K Sailaja; V R Rao; Satish Yadav; R Rajasekhar Reddy; D Surekha; D Nageswara Rao; D Raghunadharao; S Vishnupriya
Journal:  J Nat Sci Biol Med       Date:  2012-07

Review 9.  Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.

Authors:  Zodwa Dlamini; Mohammed Alaouna; Sikhumbuzo Mbatha; Ahmed Bhayat; Mzubanzi Mabongo; Aristotelis Chatziioannou; Rodney Hull
Journal:  Genes (Basel)       Date:  2021-03-15       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.